Monoclonal Antibodies
Monoclonal antibodies are established in clinical practice for the treatment of cancer, and autoimmune and infectious diseases. The first generation of antibodies has been dominated by classical IgG antibodies, however, in the last decade, the field has advanced, and, nowadays, a large proportion of...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book Chapter |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2018
|
| Subjects: | |
| Online Access: | Get Fullteks DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 01641naaaa2200277uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_53915 | ||
| 005 | 20210211 | ||
| 020 | |a 9783038428763 | ||
| 020 | |a 9783038428756 | ||
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 100 | 1 | |a Christian Klein (Ed.) |4 auth | |
| 245 | 1 | 0 | |a Monoclonal Antibodies |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2018 | ||
| 300 | |a 1 electronic resource (X, 228 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Monoclonal antibodies are established in clinical practice for the treatment of cancer, and autoimmune and infectious diseases. The first generation of antibodies has been dominated by classical IgG antibodies, however, in the last decade, the field has advanced, and, nowadays, a large proportion of antibodies in development have been engineered. This Special Issue on "Monoclonal Antibodies" includes original manuscripts and reviews covering various aspects related to the discovery, analytical characterization, manufacturing and development of therapeutic and engineered antibodies. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by-nc-nd/4.0/ |2 cc |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ | ||
| 546 | |a English | ||
| 653 | |a antibody drug conjugates | ||
| 653 | |a bispecific antibodies | ||
| 653 | |a engineered antibodies | ||
| 653 | |a antibody-like scaffolds | ||
| 653 | |a monoclonal antibodies | ||
| 856 | 4 | 0 | |a www.oapen.org |u http://www.mdpi.com/books/pdfview/book/600 |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/53915 |7 0 |z DOAB: description of the publication |